Therapeutics in all subspecialties of medicine has become more complex in recent years for a variety of reasons. Newer pharmaceuticals with greater and potentially serious toxicities are commonly used today for a large number of serious illnesses. Such drugs often interact adversely with food and with many so-called "natural" medicines such as Saint. John's wort. They may also interact with other drugs, such as those used to treat comorbidities that are outside of the realm of expertise of the physician treating the patient's most serious problem. Many newer agents need to be given in precise doses based on the patient's weight or body surface area, and some must be taken in specific relationship to food intake. Drug dosing in many instances must take into account dietary components, administration of other drugs, and patient genetics. Consequently, correct prescribing of medicines today requires a complete knowledge of the pharmacokinetics, pharmacodynamics, drug-drug interactions, and other aspects of the agent to be prescribed. Unfortunately, there is abundant evidence in the form of prescription errors (paper and electronic) 1 and increasing numbers of hospital admissions for drug toxicity in this country and many others 2 that prescribers are not always sufficiently educated to properly administer and monitor present-day therapeutics. For physicians, nurses, and physician assistants, the lack of sufficient clinical pharmacologic training can often be traced all the way back to undergraduate school.
How Big Is the Problem?
I conducted an informal poll of the chairs of 50 medical school departments of pharmacology in the United States. Thirty-nine of the 50 responded to my questioning. I asked whether formal training in pharmacology for medical students has decreased in recent years at their institution, and 35 of the 39 respondents answered in the affirmative. Most indicated that less time is currently made available to teach basic principles and that there was pressure in their schools to make the preclinical curriculum more "clinical" at the expense of emphasizing basic pharmacological principles that are relevant to therapeutics. Eleven of the 39 respondents indicated that the number of faculty who have appropriate training in pharmacology at their institution had decreased in recent years. Consequently, some medical schools have terminated pharmacology courses entirely and have gone solely to an organ-based curriculum. Published studies have reported that undergraduate medical 2-4 and nursing 5 pharmacology training in other countries is insufficient as well. The British Pharmacological Society recently published a white paper titled "Recognising the Value of Clinical Pharmacology and Therapeutics," in which they note that in the United Kingdom 6.5% of adult and 2.9% of pediatric hospital admissions were the result of adverse drug reactions. 6 Furthermore, 14.7% of hospitalized adults and 17.7% of hospitalized children experienced significant adverse drug reactions during their hospitalization. In addition, in England alone there was a 15% increase in admissions to emergency departments for drug poisoning in the last 3 years and a 10% increase in deaths from such poisoning. Furthermore, a substantial number of the poisoning cases were due to prescribed drugs. At the same time, there has been almost a doubling of the number of prescriptions dispensed in the United Kingdom over the last 10 years. The purpose of the white paper was to impress upon the National Health Service that there is a critical shortage of clinical pharmacologists in the United Kingdom and that clinical pharmacologists are essential to teach new physicians to prescribe drugs safely and effectively, and to work with industry and clinical researchers in the design of clinical trials.
According to the World Health Organization, 7 the roles of clinical pharmacologists are (a) critical evaluation of new and old treatments to assist the practicing physician in evaluating the strength of documentation about efficacy and safety for a specific regimen compared with alternative options, (b) to serve on hospital therapeutics committees, (c) to perform drug utilization studies and provide drug information services, (d) to provide pharmacovigilance and continuing medical education, (e) to provide drug monitoring and pharmacogenetic services, and (f) to provide direct patient services such as close monitoring of patients receiving polypharmacy for multiple illnesses such as cancer and HIV/AIDS. Few private practices in the United States, especially in underserved or rural settings have access to such expertise, yet it is clear that simply intervention by a pharmaceutical expert in prescribing drugs can significantly reduce inappropriate prescribing and reduce adverse drug reactions, 8 both of which are common. 1 The above strongly suggests that health care professionals who prescribe drugs need better education in clinical pharmacology and that education should begin in medical and nursing schools and should continue throughout the duration of one's career. The 6-step method proposed by the World Health Organization is a validated tool for pharmacological education in medical schools and should be considered for implementation in all medical schools. In a large study at a Netherlands medical school, this method was implemented and was shown to significantly improve students' knowledge of basic and clinical pharmacology and their pharmacotherapy skills. In addition, students' satisfaction with pharmacology education increased significantly as did their confidence in prescribing drugs. 9 Clinical pharmacologists working hand in hand with other medical subspecialists can play an important role in physician and nurse continuing education and in reducing inappropriate prescribing and serious adverse drug reactions. They can also be instrumental in increasing patient adherence with prescribed medicines. At present, there are only 9 accredited clinical pharmacology fellowship programs in the United States. 10 More are needed, and clinical pharmacologists need to have a greater role in the prescribing of complex pharmaceutical regimens commonly used in many medical subspecialties today. They also need to be more involved in the design of clinical trials in industry and academia.
What Can We Do?
The American College of Clinical Pharmacology believes that there is an urgent need to improve and expand clinical pharmacology education in undergraduate physician and nursing training. To that end, a major conference on undergraduate clinical pharmacology education involving academic medical, nursing, pharmacy and clinical pharmacology societies should be convened to make recommendations for enhancing such education. The output of this conference should include concrete steps for implementing clinical pharmacology training in medical and nursing education. In addition, the conference should discuss mechanisms for strengthening continued postgraduate education and methods for enhancing the medical subspecialty of clinical pharmacology.
Contemporary drug therapy is too important to be learned solely "on the job." Future clinicians must have a solid background in clinical pharmacology and therapeutics so that they are well prepared to use and study today's therapeutics, as well as those on the horizon. Without such training, it is likely that the incidence of adverse drug reactions and inappropriate prescribing will continue to rise.
